Table 3. KEGG pathways of DEGs involved in developmental process.
| Depot | KEGG ID | Terms | P-value |
| Omental | hsa04360 | Axon guidance | 3.25E-06 |
| hsa05200 | Pathways in cancer | 3.81E-04 | |
| hsa05217 | Basal cell carcinoma | 8.91E-04 | |
| hsa05340 | Primary immunodeficiency | 2.95E-03 | |
| hsa04514 | Cell adhesion molecules (CAMs) | 4.37E-03 | |
| hsa04512 | ECM-receptor interaction | 9.97E-03 | |
| subcutaneous | hsa04510 | Focal adhesion | 1.97E-05 |
| hsa04512 | ECM-receptor interaction | 2.39E-05 | |
| hsa05200 | Pathways in cancer | 3.60E-04 | |
| hsa04360 | Axon guidance | 6.61E-04 | |
| intramuscular | hsa05410 | Hypertrophic cardiomyopathy (HCM) | 1.24E-13 |
| hsa05414 | Dilated cardiomyopathy | 7.07E-12 | |
| hsa05200 | Pathways in cancer | 1.19E-11 | |
| hsa04510 | Focal adhesion | 5.76E-10 | |
| hsa04512 | ECM-receptor interaction | 5.21E-07 | |
| hsa04350 | TGF-beta signaling pathway | 8.81E-07 | |
| hsa04360 | Axon guidance | 1.64E-05 | |
| hsa05219 | Bladder cancer | 2.79E-05 | |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 7.71E-05 | |
| hsa04010 | MAPK signaling pathway | 2.84E-04 | |
| hsa04810 | Regulation of actin cytoskeleton | 3.64E-04 | |
| hsa04630 | Jak-STAT signaling pathway | 6.07E-04 | |
| hsa04060 | Cytokine-cytokine receptor interaction | 1.14E-03 | |
| hsa04270 | Vascular smooth muscle contraction | 1.19E-03 | |
| hsa04310 | Wnt signaling pathway | 1.22E-03 | |
| hsa04115 | p53 signaling pathway | 1.76E-03 | |
| hsa05222 | Small cell lung cancer | 2.73E-03 | |
| hsa04340 | Hedgehog signaling pathway | 5.99E-03 | |
| hsa04020 | Calcium signaling pathway | 6.18E-03 | |
| hsa05210 | Colorectal cancer | 8.31E-03 |